Michael S. Gunter, Interim CEO at ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ (HRT), bought 100 shares at $2.39 ($239) on 2012-12-03, disclosed to the SEC on 2012-12-10.
Open-market purchase of $239 HRT by Interim CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| HRT | BUY | 2012-02-14 | $1K | — | Filing → |
| HRT | BUY | 2011-12-15 | $2K | — | Filing → |
| HRT | BUY | 2011-11-30 | $8K | — | Filing → |